Report Detail
Global (United States, European Union and China) Binge Eating Disorder Drug Market Research Report 2019-2025
- RnM3686351 |
- 20 August, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase risk. Signs and symptoms include eating unusually large amounts of food, frequently eating alone, feeling that eating behavior is out of control and experiencing depression and anxiety. Treatment includes psychotherapy, medications and behavioral weight-loss programs.
In 2019, the market size of Binge Eating Disorder Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Binge Eating Disorder Drug.
This report studies the global market size of Binge Eating Disorder Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Binge Eating Disorder Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Roche
Chronos Therapeutics
Heptares
Novo Nordisk
Omeros Corp
Sunovion Pharmaceuticals
Opiant Pharmaceuticals
...
Market Segment by Product Type
Antidepressants
Anticonvulsants
Anti-obesity Medications
Market Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Binge Eating Disorder Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Binge Eating Disorder Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Binge Eating Disorder Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Binge Eating Disorder Drug Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Antidepressants
- 1.3.3 Anticonvulsants
- 1.3.4 Anti-obesity Medications
- 1.4 Market Segment by Application
- 1.4.1 Global Binge Eating Disorder Drug Market Share by Application (2019-2025)
- 1.4.2 Retail Pharmacies
- 1.4.3 Hospital Pharmacies
- 1.4.4 Online Pharmacies
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Binge Eating Disorder Drug Market Size
- 2.1.1 Global Binge Eating Disorder Drug Revenue 2014-2025
- 2.1.2 Global Binge Eating Disorder Drug Sales 2014-2025
- 2.2 Binge Eating Disorder Drug Growth Rate by Regions
- 2.2.1 Global Binge Eating Disorder Drug Sales by Regions 2014-2019
- 2.2.2 Global Binge Eating Disorder Drug Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Binge Eating Disorder Drug Sales by Manufacturers
- 3.1.1 Binge Eating Disorder Drug Sales by Manufacturers 2014-2019
- 3.1.2 Binge Eating Disorder Drug Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Binge Eating Disorder Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Binge Eating Disorder Drug Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Binge Eating Disorder Drug Market Concentration Ratio (CR5 and HHI)
- 3.3 Binge Eating Disorder Drug Price by Manufacturers
- 3.4 Key Manufacturers Binge Eating Disorder Drug Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Binge Eating Disorder Drug Market
- 3.6 Key Manufacturers Binge Eating Disorder Drug Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Antidepressants Sales and Revenue (2014-2019)
- 4.1.2 Anticonvulsants Sales and Revenue (2014-2019)
- 4.1.3 Anti-obesity Medications Sales and Revenue (2014-2019)
- 4.2 Global Binge Eating Disorder Drug Sales Market Share by Type
- 4.3 Global Binge Eating Disorder Drug Revenue Market Share by Type
- 4.4 Binge Eating Disorder Drug Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Binge Eating Disorder Drug Sales by Application
6 United States
- 6.1 United States Binge Eating Disorder Drug Breakdown Data by Company
- 6.2 United States Binge Eating Disorder Drug Breakdown Data by Type
- 6.3 United States Binge Eating Disorder Drug Breakdown Data by Application
7 European Union
- 7.1 European Union Binge Eating Disorder Drug Breakdown Data by Company
- 7.2 European Union Binge Eating Disorder Drug Breakdown Data by Type
- 7.3 European Union Binge Eating Disorder Drug Breakdown Data by Application
8 China
- 8.1 China Binge Eating Disorder Drug Breakdown Data by Company
- 8.2 China Binge Eating Disorder Drug Breakdown Data by Type
- 8.3 China Binge Eating Disorder Drug Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Binge Eating Disorder Drug Breakdown Data by Company
- 9.2 Rest of World Binge Eating Disorder Drug Breakdown Data by Type
- 9.3 Rest of World Binge Eating Disorder Drug Breakdown Data by Application
- 9.4 Rest of World Binge Eating Disorder Drug Breakdown Data by Countries
- 9.4.1 Rest of World Binge Eating Disorder Drug Sales by Countries
- 9.4.2 Rest of World Binge Eating Disorder Drug Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Roche
- 10.1.1 Roche Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Binge Eating Disorder Drug
- 10.1.4 Binge Eating Disorder Drug Product Introduction
- 10.1.5 Roche Recent Development
- 10.2 Chronos Therapeutics
- 10.2.1 Chronos Therapeutics Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Binge Eating Disorder Drug
- 10.2.4 Binge Eating Disorder Drug Product Introduction
- 10.2.5 Chronos Therapeutics Recent Development
- 10.3 Heptares
- 10.3.1 Heptares Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Binge Eating Disorder Drug
- 10.3.4 Binge Eating Disorder Drug Product Introduction
- 10.3.5 Heptares Recent Development
- 10.4 Novo Nordisk
- 10.4.1 Novo Nordisk Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Binge Eating Disorder Drug
- 10.4.4 Binge Eating Disorder Drug Product Introduction
- 10.4.5 Novo Nordisk Recent Development
- 10.5 Omeros Corp
- 10.5.1 Omeros Corp Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Binge Eating Disorder Drug
- 10.5.4 Binge Eating Disorder Drug Product Introduction
- 10.5.5 Omeros Corp Recent Development
- 10.6 Sunovion Pharmaceuticals
- 10.6.1 Sunovion Pharmaceuticals Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Binge Eating Disorder Drug
- 10.6.4 Binge Eating Disorder Drug Product Introduction
- 10.6.5 Sunovion Pharmaceuticals Recent Development
- 10.7 Opiant Pharmaceuticals
- 10.7.1 Opiant Pharmaceuticals Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Binge Eating Disorder Drug
- 10.7.4 Binge Eating Disorder Drug Product Introduction
- 10.7.5 Opiant Pharmaceuticals Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Binge Eating Disorder Drug Sales Channels
- 11.2.2 Binge Eating Disorder Drug Distributors
- 11.3 Binge Eating Disorder Drug Customers
12 Market Forecast
- 12.1 Global Binge Eating Disorder Drug Sales and Revenue Forecast 2019-2025
- 12.2 Global Binge Eating Disorder Drug Sales Forecast by Type
- 12.3 Global Binge Eating Disorder Drug Sales Forecast by Application
- 12.4 Binge Eating Disorder Drug Forecast by Regions
- 12.4.1 Global Binge Eating Disorder Drug Sales Forecast by Regions 2019-2025
- 12.4.2 Global Binge Eating Disorder Drug Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Binge Eating Disorder Drug. Industry analysis & Market Report on Binge Eating Disorder Drug is a syndicated market report, published as Global (United States, European Union and China) Binge Eating Disorder Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Binge Eating Disorder Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
